Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 avr. 2026 16h05 HE | Source: Orrstown Financial Services, Inc.

Orrstown Financial Services, Inc. Announces Date of First Quarter 2026 Earnings Release, Conference Call and Webcast

HARRISBURG, Pa., April 13, 2026 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (NASDAQ: ORRF), the holding company of Orrstown Bank, announced today that it will report first quarter 2026...
13 avr. 2026 16h05 HE | Source: Weyco Group

WEYCO Group, Inc. First Quarter 2026 Earnings Conference Call

Milwaukee, WI, April 13, 2026 (GLOBE NEWSWIRE) -- WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce first quarter 2026 financial results after the close on Tuesday,...
13 avr. 2026 16h05 HE | Source: Sana Biotechnology, Inc

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will...
13 avr. 2026 16h01 HE | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock

SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced that it intends to offer and sell, in an underwritten public offering and...
13 avr. 2026 16h01 HE | Source: Revolution Medicines, Inc.

Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...
13 avr. 2026 15h31 HE | Source: Quranium

As “Q-Day” accelerates, Quranium is already ahead of the Curve

New York City, NY, April 13, 2026 (GLOBE NEWSWIRE) -- A series of recent breakthroughs and warnings from global technology leaders have accelerated concerns around “Q-Day” - the moment quantum...
13 avr. 2026 15h24 HE | Source: Levi & Korsinsky, LLP

ODD Investor Alert: ODDITY Tech Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Certified False Statements: Levi & Korsinsky

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in ODDITY Tech Ltd. (NASDAQ: ODD) of a pending securities class action. Class Period: February 26, 2025...
13 avr. 2026 15h20 HE | Source: Sezzle

Sezzle and Minnesota Timberwolves Bring their Community to Center Court

Minneapolis, MN, April 13, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // - As the Minnesota Timberwolves played their final regular-season home game on April 12th,...
13 avr. 2026 15h20 HE | Source: MyBookie

Free Spins No Deposit Bonus USA 2026 | Online Casino Real Money No Deposit Bonus By MyBookie

New York City, NY, April 13, 2026 (GLOBE NEWSWIRE) -- Free spins no deposit bonus allows users to try casino games without depositing money first. MyBookie is one of the platforms gaining...
13 avr. 2026 15h15 HE | Source: Levi & Korsinsky, LLP

TCOM Investor Alert: Trip.com Group Limited Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Understating Anti-Monopoly Regulatory Risk: Levi & Korsinsky

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Trip.com Group Limited (NASDAQ: TCOM) that a class action lawsuit has been filed on behalf of...

Page précédente

Page suivante